----item----
version: 1
id: {2F5770D2-CDB8-4880-A774-2910AF1E4525}
database: master
path: /sitecore/content/Pharma/MedtechInsight/Home/Articles/1995/01/30/Johnson and Johnson reaches $2 billion earnings target
parent: {7791BF15-2986-498D-9ED7-B919FE9E17BD}
name: Johnson and Johnson reaches $2 billion earnings target
master: {00000000-0000-0000-0000-000000000000}
template: {11380B5D-3531-4570-B213-EFC5312266E4}
templatekey: Article

----field----
field: {A4F985D9-98B3-4B52-AAAF-4344F6E747C6}
name: __Workflow
key: __workflow
content-length: 38

{926E6200-EB76-4AD4-8614-691D002573AC}
----version----
language: en
version: 1
revision: e4da42b8-f483-4a94-857e-3569d38aeeca

----field----
field: {5BA0578F-65B7-4C22-8233-1603D698D8A4}
name: Summary
key: summary
content-length: 281

<p>Profits at Johnson & Johnson in fiscal 1994 topped $2,000 million for the first time, with its Professional division becoming the company's largest operation. The division contributed 35% to total turnover of $15,734 million and saw its own sales increase 10% over the year.</p>
----field----
field: {2D750EFF-9058-4ABF-A7FF-57FFE5DA1E3C}
name: Title
key: title
content-length: 54

Johnson and Johnson reaches $2 billion earnings target
----field----
field: {446A339B-E1D9-4DE1-8B5E-DB7942EF1723}
name: Body
key: body
content-length: 1162

<p>Profits at Johnson & Johnson in fiscal 1994 topped $2,000 million for the first time, with its Professional division becoming the company's largest operation. The division contributed 35% to total turnover of $15,734 million and saw its own sales increase 10% over the year.</p><pre>Johnson & Johnson results 1994 ($ millions) 1994 1993 % change Professional 5,325 4,824 +10.4 domestic 2,977 2,797 + 6.4 international 2,348 2,027 +15.8 Pharmaceutical 5,158 4,490 +14.9 Consumer 5,251 4,824 + 8.9 Total 15,734 14,138 +11.3 Net income 2,006 1,787 +12.3 (ended Dec 31st)</pre><p>J&J says growth in the Professional division can be attributed to sales of Ethicon Endo-Surgery's minimally invasive surgical instruments; Acuvue disposable contact lenses; Lifescan's blood glucose monitoring systems; and the Palmaz-Schatz stent.</p><p>The division acquired Eastman Kodak's Clinical Diagnostics business in November (see Clinica No 620, pp 1-2), which boosted fourth-quarter results. In the three months ended December 31st, 1994, turnover was up 17.3% to $1,449 million compared with the same period in 1993. International sales increased 22.1% to $631 million.</p>
----field----
field: {0212FC0F-953B-461C-B4D9-B7483A4D4F1B}
name: Taxonomy
key: taxonomy
content-length: 38

{2EDCC1FF-26E4-4C6E-AF73-0F43F0F033B8}
----field----
field: {8F4EE718-6FA0-42A5-85C4-6C8FE8B1FCD4}
name: Navigation Title
key: navigation title
content-length: 54

Johnson and Johnson reaches $2 billion earnings target
----field----
field: {7C4FC796-1311-4DAA-81AC-85EAA2C1C108}
name: Actual Publish Date
key: actual publish date
content-length: 15

19950130T000000
----field----
field: {BDF7C8E1-869E-49FF-B9F5-854B3081A45D}
name: Created Date
key: created date
content-length: 15

19950130T000000
----field----
field: {C926A72A-39DA-446D-B78C-2A650F820A73}
name: Modified Date
key: modified date
content-length: 15

19950130T000000
----field----
field: {1616FE67-7278-4169-948E-C29B00EC8781}
name: Article Number
key: article number
content-length: 8

MT051276
----field----
field: {2C985172-2B37-4CFE-AEDE-2A42EC833941}
name: Content Type
key: content type
content-length: 38

{832554E5-EC9E-4747-8623-6770D36CAF32}
----field----
field: {31603F25-6D9C-4954-BCDE-342E1E184A30}
name: Meta Title Override
key: meta title override
content-length: 54

Johnson and Johnson reaches $2 billion earnings target
----field----
field: {AE1BD751-D4E7-49CB-96C4-62E995A06B51}
name: Article Category
key: article category
content-length: 4

News
----field----
field: {0F6C8F42-01DC-4E05-B63E-AA25D8AA0E09}
name: Legacy Publication
key: legacy publication
content-length: 38

{FF38DC83-07D4-43F0-8C55-84EB64FAF35A}
----field----
field: {5795FF15-0942-41FF-8A77-3B73185F5E1B}
name: Escenic ID
key: escenic id
content-length: 6

253045
----field----
field: {25BED78C-4957-4165-998A-CA1B52F67497}
name: __Created
key: __created
content-length: 16

20160622T183813Z
----field----
field: {5DD74568-4D4B-44C1-B513-0AF5F4CDA34F}
name: __Created by
key: __created by
content-length: 18

sitecore\Anonymous
----field----
field: {8CDC337E-A112-42FB-BBB4-4143751E123F}
name: __Revision
key: __revision
content-length: 36

e4da42b8-f483-4a94-857e-3569d38aeeca
----field----
field: {D9CF14B1-FA16-4BA6-9288-E8A174D4D522}
name: __Updated
key: __updated
content-length: 16

20160622T183814Z
----field----
field: {BADD9CF9-53E0-4D0C-BCC0-2D784C282F6A}
name: __Updated by
key: __updated by
content-length: 18

sitecore\Anonymous
----field----
field: {3E431DE1-525E-47A3-B6B0-1CCBEC3A8C98}
name: __Workflow state
key: __workflow state
content-length: 38

{962542F5-554E-4DE8-BE4C-B0796FDAC854}
